Andrew Lowy is an Oncology physician affiliated with UC San Diego Health System. OpenAlex indexes 867 publications with 24,086 citations (h-index 77); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Surgical Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 W Arbor Dr
San Diego, CA 921039000
Telephone
800-926-8273Provider last certified this registry record 17 Nov 2025.
Clinical trials
- Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
Sponsor: University of California, San Diego
- Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer
Sponsor: Hitendra Patel
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20242 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20236 payments
- ABBVIE INC.Program year20233 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
10 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- Targeted degradation of glycoimmune checkpoints Siglec-7 and -9 for cancer immunotherapy
Scripps Research Institute, the
FY2026$748,410R01CA304089 - Defining the Role of MICAL2 in KRAS Mediated Pancreatic Duct Neoplasia
University of California, San Diego
FY2026$643,013R01CA309448 - Regulation of PDAC metabolism and immunity by collagen and its cleavage products
Sanford Burnham Prebys Medical Discovery Institute
FY2025$1,152,768U01CA274295
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test
Communications Medicine
2022 - Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Spragg, MD
UC San Diego Health System
Rafael Bejar, MD, PhD
UC San Diego Health System
Zea Borok, MD
UC San Diego Health System
Patricia Thistlethwaite, MD/PHD
UC San Diego Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”